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ABSTRACT Proposed models for the catalytic subunit of the E,E2-ATPases (ion pumps) predict that the first four transmembrane
domains (M, - M .) reside in the NH2 terminal one-third of the molecule, and the remainder (Ms - MlO) in the COOH terminal
one-third. The amino-acid sequences for the 5'-(p-fluorosulfonyl)-benzoyl-adenosine (FSBA) binding region residing just before
Mssegment are very well conserved among distinct ion pumps. Taking advantage of these models, we have constructed a set of
chicken chimeric ion pumps between the (Na+ + K+)-ATPase a-subunit and the Ca2+-ATPase using the FSBA-binding site as an
exchange junction, thereby preserving overall topological structure as E,E2 ATPases. From various functional assays on these
chimeric ion pumps, including ouabain-inhibitable ATPase activity, Ca2+ binding, Ca2+ uptake, and subunit assembly based on
immuno-coprecipitation, the following conclusions were obtained: (a) A (Na+ + K+)-ATPase inhibitor, ouabain, binds to the regions
before M. in the a-subunit and excerts its inhibitory effect. (b) The regions after Ms of the (Na+ + K+)-ATPase a-subunit bind the
J3-subunit. even when these regions are incorporated into the corresponding domains in the Ca2+-ATPase. (c) The corresponding
domains of the Ca2+-ATPase, the regions after Ms' bind ,sCa even when it is incorporated into the corresponding position of the
(Na+ + K+)-ATPase a-subunit.
INTRODUCTION
Recent advances in recombinant DNA technology have
permitted the dissection of distinct molecular domains
of functional proteins. One approach to identify the
critical domains that determine specificity of distinct
molecules for particular ions, inhibitors, and subunits is
to construct chimeric molecules between distinct func-
tional proteins that have very similar structures. So far,
this type of approach has been successful in studying
structure-function relationships between (a) the a- and
the 13-adrenergic receptors (1), (b) muscarinic acetylcho-
line receptor subtypes (2), (c) the chicken and human
EGF-receptors that have different affinity for EGF (3),
and (d) the skeletal and cardiac isoforms of the dihydro-
pyridine-sensitive Ca2+ channel (4). In these studies, the
entire higher order structures are likely to be preserved
as functional proteins with some kind of common
fundamental function. We have been taking this type of
approach to investigate the structure-function relation-
ship of ion-translocating ATPases (E1Ez-type ATPases
or ion pumps).
Each ion pump has a strict specificity for ions and is
blocked by specific inhibitors; the (Na+ + K+)-ATPase
is blocked by a plant alkaloid, ouabain, the sarcoplasmic
reticulum (SR) Caz+-ATPase by thapsigargin (5), and
the (H+ + K+)-ATPase by omeprasol (6, 7). Some ion
pumps (e.g., the Caz+-ATPase) have a single catalytic
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subunit with a molecular weight of - 100 kD, and the
others (e.g., the [Na+ + K+]-ATPase and the [H+ + K+]-
ATPase) consist of two subunits; a catalytic a-subunit
and a smaller glycoprotein 13-subunit (8-10). Ap-
proaches employing construction and expression of
chimeric ion pumps will be able to identify the critical
domains that determine specificity for particular ions,
inhibitor-binding sites, and/or subunit assembly, comple-
menting the information obtained by the other ap-
proaches such as chemical modification (11).
EXPERIMENTAL PROCEDURES
Strategy
Fig. 1 illustrates a general model for the catalytic subunit
of a variety of E1Ez-type ATPases including the
(Na+ + K+)- and the Caz+-ATPase. This model is consis-
tent with many biochemical investigations (8, 11) and
recent cDNA cloning and sequencing studies (12, 13).
The key features of this model are: (a) The catalytic
subunits of the E1Ez-ATPases form very similar higher
order structures with 7-10 membrane spanning domains
even though the primary amino acid sequences of these
ATPases are significantly different ( - 30% homology).
(b) There are four evolutionarily conserved regions; the
region between M z and M3, phosphorylation-domain,
ftuorescein-isothio-cyanate (FITC) binding-domain, and
220 0006-3495/92/04/220/08 $2.00 Biophys. J. ~ Biophysical Society
Volume 62 Discussions 1992 220-227
Subunit Assembly
--Ser-Ser-Leu-Thr-GIy-GIu-Ser--
FIGURE 1 General model for topological orientation of the E,E,-
ATPase catalytic subunit across the membrane. Amino acid sequences
for four highly conserved regions between different ATPases are
shown; region between M, and M2, phosphorylation site (Pi), and
FITC- and FSBA-binding domains. Potential transmembrane seg-
ments are numbered, and critical domains identified in this studies are
also indicated; ouabain-binding segment, Ca2+-binding region, and
assembly domain with the J3-subunit.
the 5'-(p-fluorosulfonyl)-benzoyl-adenosine (FSBA)
binding region. The amino acid sequences for these
regions are also shown in Fig. 1. (c) The first four
transmembrane segments are localized just before the
conserved phosphorylation domain, and the remainder
after the FSBA-binding region. (d) The middle of the
molecule is located on the cytoplasm face of the mem-
brane and contains three conserved regions, the phospho-
rylation site, the FITC-binding site and the FSBA-
binding site.
Using the general model, one might speculate that
different types of ion pumps may be formed by just
combining four different portions (the NHz-terminal
fragment before the phosphorylation site, the fragment
between the phosphorylation- and FITC-sites, the frag-
ment between the FITC and FSBA-site, and the COOH-
terminal region after the FSBA-site) at three common
junctions, the phosphorylation site, the FITC-binding
domain and the FSBA-binding region. Indeed, this is
our strategy for dissection of functional domains of the
E1Ez-ATPase. Utilizing a heterologous expression sys-
tem allows us to identify the avian proteins in trans-
fected mammalian cells using monoclonal antibodies
specific to the avian ion pumps. Additionally, it is
possible to monitor enzymatic functions of the relatively
ouabain-sensitive chicken molecules expressed in mouse
L cells, of which the (Na+ + K+)-ATPase is relatively
ouabain-resistant.
Chimeric mutant cDNAs encoding
chicken Na-pump/Ca-pump chimeric
molecules
Construction of the chimeric cDNAs has been described
previously (14). Briefly, a unique restriction site, EcoNI,
which is endogenous to both the SR calcium pump
eDNA (15) and the PM sodium pump cd-subunit cDNA
(16), was used as an exchange point for recombination.
This exchange occurred at nucleotide 2134 (from the
translation initiation site) on the aI-subunit cDNA and
at nucleotide 2170 on the calcium pump cDNA, both of
which encode lysine (Lys*) residues within the evolution-
arilyconserved FSBA-bindingdomain (17,11) (-Pro-Ala-
Leu-Lys*-Lys-Ala-). These chimeric cDNAs and wild
type cDNAs were cloned into an expression plasmid,
DLSRaa (18), which contains the SV40 late promoter
and a retrovirus enhancer for high level of mRNA
production suitable for transient expression. For stable
expression, a plasmid, pSVDF (19) derived from
pSVzCAT (20), was used.
Transfection and cell culture
COS-l cells growing in a 150-mm culture dish were
cotransfected with 8 J.l.g of DLSRaa DNA containing
either chimeric or wild-type cDNAs and 8 J.l.g of DL-
SRaalcDNA encoding the chicken (Na+ + K+)-ATPase
~-subunit (19). This was done by using a DEAE-dextran
method. Mouse L cells (in 100-mm culture dish) express-
ing the ~1-subunit of the chicken (Na+ + K+)-ATPase
(19) were cotransfected by the calcium phosphate precip-
itation method with 0.1 J.l.g of pSVneo DNA and 1 J.l.g of
pSVDF/chimeric or wild-type cDNA. The transfected
cells were selected in a media containing G418 sulfate
(Gibco Laboratories, Lawrence, MA) (,.., 500 J.l.g/ml),
and then screened for expression of the chicken chi-
meric molecules using chicken specific monoclonal anti-
bodies (see below).
ATPase assay
The rate of ATP hydrolysis was determined as described
previously (21); for each ADP produced in the assay, a
molecule of NADH was oxidized to NAD+ and this was
monitored spectroscopically by a decrease in absorbance
at 340 nm. The ATPase assay medium (1 ml) contained 5
J.l.1 of cell homogenate (300-500 J.l.g total protein), 120
mM NaC!, 15 mM KCI, 30 mM triethanolamine pH 7.4,
4 mM MgClz' 3 mM NaATP, 0.5 mM EGTA, 2 mM
NaN3, 2.5 mM phosphoenolpyruvate, 0.5 mM NADH,
10 Ulml pyruvate kinase, 30 Ulml lactate dehydroge-
nase, and 0.2% Triton X-lOO. Ouabain-sensitive
nATPase activity was obtained by calculating the differ-
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ence in activity in the presence and absence of 1 mM
ouabain.
Immunoprecipitation and monoclonal
antibodies
Monoclonal antibodies 7C (specific for the chicken
(Na+ + K+)-ATPase aI-subunit [16]) and 5D2 (specific
for the chicken SR Ca2+-ATPase (22), and TRITC-
labeled goat-anti-mouse IgG were used to identify the
chicken proteins in transfected cells. Metabolic labeling
procedure followed by immunoprecipitation (23, 24)
were employed to characterize the ability of chimeric
molecules to assemble with the chicken (Na+ + K+)-
ATPase ~-subunit. Transfected cells grown in 2 ml
DMEM containing fetal calf serum/35 mm dish were
subjected to incubation in methionine-free DMEM
containing 50 ~Ci/ml pSS]methionine to label cellular
proteins metabolically. Following the labeling, the cells
were solubilized with 3 ml extraction buffer (1 % Triton
X·100, 150 mM NaCl, 50 mM Tris-HCI (pH 7.5), 1 mM
EDTA, 2 mM benzamidine, 5 mM N-ethylmaleimide,
and 1 mg/ml bacitracin). Mter cell debris was removed
by sedimentation at 15,000 g for 15 min, 50 ~l of packed
Sepharose 4B beads coupled to monoclonal antibody 24,
specific to the chicken (Na+ + K+)-ATPase ~-subunit
(23, 25), were added to the supernatant and incubated
for 18 h at 4°C on a rocking platform. The immunobeads
were washed thoroughly, and the bound antigen was
eluted from the beads with 2 x 100 ~l elution solution
containing 0.5% deoxycholate and 0.1 M triethylamine
(pH 11.5). Metabolically labeled and immunobead-
purified materials were analyzed on SDS-PAGE fol-
lowed by fluorography.
45Ca-transport and 45Ca-binding
assays using microsomal
preparation from cultured cells
4SCa2+-binding and -transport assays were done in mi-
crosomal fractions of transfected or untransfected COS-1
cells, as described previously (26, 27). A typical microso-
mal preparation was prepared from twenty 150-mm
culture dishes containing COS-1 cells 72 h after transfec-
tion. The final microsomal fraction containing chicken
ATPases was stored at -70°C, for at longest two weeks,
until used. The assay reactions for 4SCa2+ uptake were
started by adding microsomal preparation into the assay
medium (20 mM MOPS [pH 7.0], 80 mM KCI, 5 mM
MgCI2, 5 mM Na-oxalate, 200 ~M EDTA, 2.5 mM ATP,
200 ~M CaCI2, and 4SCa [0.4 mCi/ml]) at 25°C. At
various time points after the addition of the microsomal
preparation, 1 ml aliquots of the reaction mixture (10 ~g
protein/ml) were filtered through a Millipore filter and
washed with 10 mM MOPS (pH 7.0) and 2 mM LaCl),
and the radioactivity remaining on the filter was counted.
For 4SCa2+-binding assays, microsomal fractions (200
~g/ml) were incubated at 37°C for 90 min in the assay
medium (100 mM MOPS [pH 6.8], 80 mM KCI, 100 ~M
CaCl2, 2.6 ~Ci 4SCa2+, 200 ~M EGTA, 4 ~M A23187),
quenched with 2 mM LaCI) and 10 mM MOPS (pH 6.8)
and then, filtered through a Millipore filter for counting.
Specific 4SCa2+ binding was defined as the difference
between the binding of 4SCa2+ in the presence and
absence of 500 ~M chromium ATP (Cr-ATP).
RESULTS AND DISCUSSION
Ouabain-binding domains in the
(Na+ + K+)-ATPase
Several gene-transfer experiments have indicated that
the (Na+ + K+)-ATPase a-subunit is responsible for
affinity for ouabain (16, 28-31). Recently, using site-
directed mutagenesis, Price and Lingrel (31) have dem-
onstrated that the extracellular domain between M1 and
M2consisting of 11 amino acids (especially Argl16 and
Asp127) is the major ouabain binding domain. However,
whether ouabain binds only to these sites or to addi-
tional site(s) to exert its action remains to be deter-
mined; the (Na+ + K+)-ATPase a-subunit may posses
multiple ouabain-binding sites. To address this question,
we have transfected mouse L cells with cDNAs encoding
chicken Ca2+/(Na+ + K+)-ATPase chimeric molecules.
Because the (Na+ + K+)-ATPase of mouse L cells is
relatively ouabain-resistant, this avian/mouse hybrid
system allows us to monitor enzymatic functions of the
relatively ouabain-sensitive chimeric molecules.
Mouse L cells that express the chicken sodium-pump
~-subunit (19) were transfected with these chimeric
cDNAs, and selected for expression of the encoded
chicken proteins using monoclonal antibodies 7C (spe-
cific to the chicken [Na+ + K+]-ATPase a-subunit [16])
and 5D2 (specific to the chicken SR Ca2+-ATPase [22]).
The cloned cells were then subjected to ATPase activity
assays in the presence and absence of ouabain. Fig. 2
shows effect of various concentrations of ouabain on the
ATPase activity measured in the buffer (in the presence
of Na+and K+, and in the absence of Ca2+) optimized for
the (Na+ + K+)-ATPase. The ouabain-inhibition of the
ATPase activity of cells, transfected with DNA encoding
either the wild-type (Na+ + K+)-ATPase a-subunit or
Chimera I, is biphasic; - 60% shows ICso of < 10 ~M
and the rest ICso of - 300 ~M. On the other hand,
ouabain has a monophasic inhibitory effect (ICso: - 300
~M) in untransfected mouse Ltk- cells. Because the
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FIGURE 3 Effect of calcium ion on the ATPase activity of homoge-
nate from transfected cells. The same ATPase assay system as
described in Fig. 2 was used, and the ATPase activity was compared
before and after addition of 300 j.LM CaC!2 (resulting in -4 j.LM free
Ca2+) into the reaction system. The ATPase activity of transfected cells
before and after Ca2+-addition was 92.6 and 221 nmol ATP cleaved/mg
protein/min, whereas the activity of control cells before and after
Ca2+-addition was 86.7 and 94.1 nmol ATP cleaved/mg protein/min.
The ATPase activity of Chimera I could be stimulated by
adding Ca2+ to the assay system (Fig. 3), indicating that
the COOH terminal one-third of the Ca2+-ATPase
possess the ability to interact with Ca2+ ions. This effect
of Ca2+ ions could be detected neither in untransfected
mouse L cells nor in cells transfected with wild-type
cd-subunit DNA. To characterize the ability of this
region ofthe Ca2+-ATPase to bind Ca2+ions further, we
have established many mouse L cell lines stably trans-
fected with the chicken wild-type Ca2+-ATPase cDNA as
well as Chimera II cDNA. However, we have not been
able to detect Ca2+-stimulated ATPase activity for un-
known reasons. Therefore, to detect Ca2+-dependent
function of the chicken ATPase molecules, we expressed
these cDNAs in COS-1 cells according to the methods
described by Clarke et al. (26, 27).
The binding of 4SCa to the microsomal fraction ob-
tained from transfected COS-1 cells was measured in
the presence of Cr-ATP. Fig. 4 shows the Ca2+-binding
ability of wild-type and chimeric ion pumps transiently
expressed in COS-1 cells; Chimera I exhibited Ca2+-
binding activity as well as the wild-type Ca2+-ATPase,
while Chimera II and the wild-type (Na+ + K+)-ATPase
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specific activity of cell homogenate varies from 50 to 100
nmol ADP cleaved/mg protein/min depending upon the
condition of cell growth, it is difficult to make a direct
comparison of the specific activity between the endoge-
nous and transfected ATPases. Therefore the data were
expressed as percentage of control so that the affinity for
ouabain can be easily compared. At present, functions of
Chimera II distinct from those of the endogenous mouse
ATPase cannot be detected in our system (see also
below).
It has been known that the calcium pump does not
bind ouabain, and that the endogenous mouse sodium
pump does not have high affinity sites for ouabain. One
of the chimeric molecules, Chimera I, consisting of the
NH2 terminal two-thirds of the cd-subunit of the ouabain-
sensitive chicken (Na+ + K+)-ATPase and the COOH
terminal one-third of the sarcoplasmic reticulum Ca2+-
ATPase exhibited ouabain-sensitive ATPase activity
very similar to that of the wild-type chicken (Na+ + K+)-
ATPase when assayed in cell homogenate. These results
that show an inhibitory effect of ouabain on the wild-
type and chimeric molecules suggest that ouabain does
not have to bind to the ectodomains after Ms' because
this high affinity site for ouabain newly appeared in
transfected cells must come from the chicken wild-type
cd-subunit and Chimera I.
Ouabain Concentration [ ~Ml
FIGURE 2 Ouabain-inhibitable ATPase activity of sodium- and cal-
cium-pump chimeric molecules_ Enzyme linked assay system was used
to measure (Na+ + K+)-ATPase activity of transfected (Chimera I,
Chimera II, and wild-type cd-subunit) and untransfected (mouse
wild-type) cell homogenates, in the presence and absence of ouabain.
ATPase activities of cell homogenate were measured in the presence
of 0.2% Triton X-loo which partially solubilizes and clears turbid
sample and allows chemicals access to both sides of the membrane.
Mitochondorial ATPase and Ca2+-ATPase activities were blocked by
addition of 2 mM NaN3 and 10 mM EGTA into the reaction mixture,
respectively. The ATPase activity (60-80 nmol ATP cleaved/mg
protein/min) that can be inhibited by 1 mM ouabain was defined as
100%.
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FIGURE 4 <sCa-binding to the microsomal fractions from COS-I cells
cotransfected with DNA encoding (0) wild-type Ca2+-ATPase, (b)
Chimera I, (c) Chimera II, and (d) wild-type (Na+ + K+)-ATPase
aI-subunit, together with DNA encoding chicken (Na+ + K+)-ATPase
~-subunit. Background was measured in cells transfected with expres-
sion vector, DLRsa, without any insert.
FIGURE 5 <sCa-uptake by the microsomal fractions from COS-I cells
cotransfected with DNA encoding (0) wild-type Ca2+-ATPase, (b)
Chimera I, (c) Chimera II, and (d) wild-type (Na+ + K+)-ATPase
aI-subunit, together with DNA encoding chicken (Na+ + K+)-ATPase
~-subunit.
a-subunit showed no Ca2+-binding activity over the
background. These results indicate that the COOH
terminal one-third of the SR Ca2+-ATPase binds Ca2+
ion with high affinity. To correlate the effect of this
Ca2+-binding to the Ca2+-transporting activity, we have
measured ATP-dependent 4SCa-uptake in the microso-
mal fractions of transfected COS-l cells. However,
Ca2+-transport activity was found only in the microsomal
fraction obtained from cells transfected with wild-type
Ca2+-ATPase DNA (Fig. 5). It might be that the critical
sites for Ca2+-binding and for ion-translocation are
different. Further effort to construct additional chimeric
molecules with Ca2+-transport activity will be necessary.
In this sense, it is noteworthy that Clarke et aI. (26) has
proposed that the transmembrane segments, Mr M7,
contain calcium-binding sites on the basis of their
demonstration that substitution of charged amino acids
in these regions resulted in loss of ion-pump activity.
Domains responsible for assembly
with the ~-subunit
It has been difficult to study functions of individual
subunits of multisubunit ion pumps, such as the
(Na+ + K+) ATPase. However, two strategies have been
successful: (a) expression of DNAs encoding ouabain-
sensitive sodium pump in cells of an ouabain-resistant
organism, and vice versa; and (b) over expression of
sodium-pump DNAs in organisms, such as Xenopus
ooeytes and yeast. By using these expression systems,
extensive studies have been carried out to explore roles
of the ~-subunit (20, 30, 32-34). The consensus idea
deduced from these studies is that the ~-subunit is
critically involved in the stabilization and transport of
the a-subunit to the plasma membrane. Transfected and
cloned mouse L cells expressing chicken chimeric ion-
pump molecules have offered a good opportunity in
which to identify the domains of the a-subunit critical
for assembly with the ~-subunit.
The criterion for the assembling ability is the immuno-
coprecipitation of the chimeric molecules by use of a
monoclonal antibody specific to the ~-subunit.We have
cloned a set of transfected mouse L cell lines expressing
either one of the chimeric molecules together with the
chicken ~-subunit, and subjected them to the immunoco-
precipitation analysis. The cells were labeled with
eSS)methionine, solubilized in 1% Triton-XlOO, and the
solubilized and labeled materials were purified by immu-
noaffinity column. The purified products were analyzed
by SDS-PAGE and fluorography. The final autoradio-
grams showed that Chimera II, consisting of the NH2
terminal two-thirds of the Ca2+ATPase and the COOH
terminal one-third of the (Na+ + K+)-ATPase a-sub-
unit, was assembled with the chicken ~-subunit (35).
This suggests that the COOH terminal one-third of the
Na pump contains the domain(s) required for assembly
with the ~-subunit,and is consistent with a recent study
of expression of sodium/calcium pump chimeric mole-
cules in Xenopus ooeytes, (36).
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CONCLUSIONS
Some of the critical domains for E,Ez-ATPase function
identified in this study are summarized in Fig. 1. First,
the ouabain-binding domains will be localized within the
NHz terminal one-third of the (Na+ + K+)-ATPase
a-subunit, whereas the domain responsible for assembly
with the ~-subunitwill reside within the COOH terminal
one-third ofthe (Na+ + K+)-ATPase a-subunit. Second,
the COOH terminal one-third of the SR Caz+-ATPase
contains the Ca2+-binding site(s). Our studies on the
structure-function relationship of E,Ez-ATPases using
chimeric approaches have been qualitative and still
incomplete in terms of quantitative analysis. In the
future, it is interesting and important to further define
inhibitor- and ion-binding regions, particularly 86Rb_
occlusion domains, Na-sensitive sites, thapsigargin-
binding regions, aiming at identifying minimal structural
requirements for specific ion-transport activity.
We wish to thank Dr. H. C. Kutchai for ATPase assays.
This work was supported by National Institutes of Health grants
GM44373 (to K. Takeyasu), HL27867 (to G. Inesi) and NS23241 (to
D. M. Fambrough). D. B. Luckie and K. L. Boyd were supported by
National Institutes of Health Training Grant T32-HL07284. K. Take-
yasu is an Established Investigator of the American Heart Association
and a member of the Cancer Center and the Diabetes Center at the
University of Virginia.
REFERENCES
1. Kobilka, B. K., T.-S. Kobilka, K. Daniel, J. W. Regan, M. G.
Caron, and R. J. Lefkowitz. 1988. Chimeric a2-, 132-adrenergic
receptors: delineation of domains involved in effector coupling
and ligand binding specificity. Science (Wash. DC). 240:1310-
1316.
2. Fukuda, K., T. Kubo, A Maeda, 1. Akiba, H. Bujo, J. Nakai, M.
Mishina, H. Higashida, E. Neher, A Marty, and S. Numa. 1989.
Selective effector coupling of muscarinic acetylcholine receptor
subtypes. Trends Pharmacoi. Sci. (SuppI.):4-10.
3. Lax, I., F. Bellot, R. Howk, A Ullrich, D. Givol, and J. Schless-
inger. 1989. Functional analysis of the ligand binding site of
EGF-receptor utilizing chimeric chicken/human receptor mole-
cules. EMBO (Eur. Moi. Bioi. Organ.) f. 8:421-427.
4. Tanabe, T., B. A Akams, S. Numa, and K. G. Beem. 1991. Repeat
I of the dihydropyridine receptor is critical in determining
calcium channel activation kinetics. Nature (Lond.). 352:800-
803.
5. Sagara, Y., and G. Inesi. 1991. Inhibition of the sarcoplasmic
reticulum Ca2+transport ATPase by thapsigargin at subnanomo-
lar concentrations. f. Bioi. Chem. 266:13503-13506.
6. Lorentzon, P., R. J. Jackson, B. Wallmark, and G. Sachs. 1987.
Inhibition of the HK ATPase by omeprazole in isolated gastric
vesicles requires proton transport. Biochim. Biophys. Acta. 897:
41-51.
7. Sachs, G., K. Munson, K. Hall, and S. J. Hersey. 1990. Gastric H+,
K +-ATPase as a therapeutic target in peptic ulcer disease. Dig.
Dis. Sci. 35:1537-1544.
8. Jorgensen, P. L., and J. P. Andersen. 1988. Structural basis for
EI-E2 conformational transitions in Na, K-pump and Ca-pump
proteins. 1. Membr. Bioi. 103:95-120.
9. Reuben, M. A, L. S. Lasater, and G. Sachs. 1990. Characteriza-
tion of a 13-subunit of the gastric H+ /K+-transporting ATPase.
Proc. Nati. Acad. Sci. USA. 87:6767-6771.
10. Shull, G. E. 1990. cDNA cloning of the 13-subunit of the rat gastric
H,K-ATPase.1. Bioi. Chem. 265:12123-12126.
11. Pedemonte, C. H., and J. H. Kaplan. 1990. Chemical modification
as an approach to elucidation of sodium pump structure-
function relations. Am. f. Physiol. 258:Cl-e23.
12. MacLennan, D. H., C. J. Brandl, B. Korczak, and N. M. Green.
1985. Amino acid sequence of a Ca2+-ATPase from rabbit
muscle sarcoplasmic reticulum deduced from its complementary
DNA sequence. Nature (Lond.). 316:696-700.
13. Shull, G. E., A Schwartz, and J. B. LingreI. 1985. Amino-acid
sequence of the catalytic subunit of the (Na+ + K+)-ATPase
deduced from a complementary DNA Nature (Lond.). 316:691-
695.
14. Luckie, D. B., K. L. Boyd, A Mizushima, Z. Shao, A P. Somlyo,
and K. Takeyasu. 1991. Expression of functional sodium and
calcium pump chimeric molecules. In The Sodium Pump:
Recent Developments. J. H. Kaplan and P. DeWeer, editors.
Rockefeller University Press, New York. 237-242.
15. Karin, N. J., Z. Kaprielian, and D. M. Fambrough. 1989. Expres-
sion of avian Ca2+-ATPase cDNA in cultured mouse myogenic
cells. Cell. Mol. Bioi. 9:1978-1986.
16. Takeyasu, K., M. M. Tamkun, K. J. Renaud, and D. M. Fam-
brough. 1988. Ouabain-sensitive (Na+ + K+)-ATPase activity
expressed in mouse L cells by transfection with DNA encoding
the a-subunit of an avian sodium pump.f. Bioi. Chem. 263:4347-
4354.
17. Ohta, T., K. Nagano, and M. Yoshida. 1986. The active site
structure of Na+ /K+-transporting ATPase: location of the 5-(p-
fluorosulfonyl)-benzoyladenosine binding site and soluble pep-
tides released by trypsin. Proc. Natl. Acad. Sci. USA. 83:2071-
2075.
18. Takebe, Y., M. Seiki, J.-I. Fujusawa, P. Hoy, K. Yokota, K.-I. Arai,
M. Yoshida, and N. Arai. 1988. SRa promoter: an efficient and
versatile mammalian cDNA expression system composed of the
simian virus 40 early promoter and the R-U5 segment of human
T-cell leukemia virus Type-l long terminal repeat. Moi. Cell.
Bioi. 8:466-472.
19. Takeyasu, K., M. M. Tamkun, N. R. Siegel, and D. M. Fambrough.
1987. Expression of hybrid (Na+ + K+)-ATPase molecules after
transfection of mouse Ltk- cells with DNA encoding the
13-subunit of an avian brain sodium pump. f. Bioi. Chem.
262:10733-10740.
20. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Moi. Cell.
Bioi. 2:1044-1051.
21. N0rby, J. G. 1988. Coupled assay of Na+, K+ ATPase activity.
Methods Enzymoi. 156:116-119.
22. Kaprielian, Z., and D. M. Fambrough. 1987. Expression of fast and
slow isoforms of the Ca2+-ATPase in developing chick skeletal
muscle. Dev. Bioi. 124:490-503.
23. Tamkum, M. M., and D. M. Fambrough. 1986. The (Na+ + K+)-
ATPase of chick sensory neurons: studies on biosynthesis and
intracellular transport.f. Bioi. Chem. 261:1009-1019.
24. Wolitzky, B. A, and D. M. Fambrough. 1986. Regulation of the
Luckieet al. Chimeric Ion Pumps 225
(Na+ + K+)-ATPase in cultured chick skeletal muscle: modula-
tion of expression by the demand for ion transport. 1. BioI. Chem.
261:9990-9999.
25. Fambrough, D. M., and E. K. Bayne. 1983. Multiple forms of
(Na+ + K+)-ATPase in the chicken. J. BioI. Chem. 258:3926-
3935.
26. Clarke, D. M., T. W. Loo, G. Inesi, and D. H. MacLennan. 1989.
Location of high affinity Ca'+ -binding sites within the predicted
transmembrane domain of the sarcoplasmic reticulum Ca'+-
ATPase. Nature (Land.). 339:476-478.
27. Clarke, D. M., K. Maruyama, T. W. Loo, E. Leberer, G. Inesi, and
D. H. MacLennan. 1989. Functional consequences of glutamate,
aspartate, glutamine, and asparagine mutations in the stalk
sector of the Ca'+ -ATPase of sarcoplasmic reticulum. J. BioI.
Chem. 264:11246-11251.
28. Emanuel, J. R., J. Shultz, X.-M. Zhou, R. B. Kent, D. Housman, L.
Cantley, and R. Levenson. 1988. Expression of an ouabain-
resistant Na, K-ATPase in CY-l cells after transfection with a
cDNA encoding the rat Na, K-ATPase aI-subunit. J. BioI.
Chem.263:7726-7733.
29. Kent, R. B., J. R. Emanuel, Y. B. Neriah, R. Levenson, and D. E.
Housman. 1987. Ouabain resistance conferred by expression of
the cDNA for a murine Na+, K+-ATPase a-subunit. Science
(Wash. DC). 237:901-903.
30. Noguchi, S., M. Mishina, M. Kawamura, and S. Numa. 1987.
DISCUSSION
Session Chairman: Ira Levin Scribes: Fen Zhang and Yinong Zhang
ROBERT FARLEY: By sequence homology, there appear to be
several regions of possible structural similarity among the different ion
pumps. I think it is reasonable to expect ions to bind to comparable
regions of different pumps. You can demonstrate Ca-stimulated ATP
hydrolysis consistent with Ca binding at a stimulatory site in Chimera I.
Have you done any experiment to show that Na and K stimulate
ATPase activity in Chimera I? This the first part of my question.
Related to this, have you excluded the possibility that the Chimera I
is in fact not a Na-K ATPase, but rather an ouabain-sensitive Ca
ATPase in which ATP hydrolysis is uncoupled from transport? If so it
would be the first example of an uncoupled ion pump to my knowledge.
DOUGLAS LUCKIE: As to your second question, we completely
agree with you. This Chimera I is highly likely to be an uncoupled
ATPase.
As to your first question, we are currently characterizing the
properties of Chimera I. As far as we know, Chimera I does not pump
Ca, while it binds Ca. We think this might mean that ion binding and
ion pumping functions are independent of one another in terms of the
structures concerned.
FARLEY: Regarding Ca binding, have you estimated the stoichiome-
try of Ca binding to this Chimera?
LUCKIE: No, I haven't done such quantification. But we hope to
estimate the stoichiometry by comparing the amounts of Ca bound and
the P, incorporated.
RAJINI RAO: Chimera I appears not to interact with the 13-subunit,
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yet it has ouabain-sensitive ATPase activity. What are the implications
for the role of the 13-subunit? My understanding is that so far the
13-subunit is required for ouabain binding, ouabain-sensitive ATPase
activity, and also for the targeting of the pump to the plasma
membrane?
KUNIO TAKEYASU: It is an interesting point. It seems that Chimera
I does not need the 13-subunit but still appears to have some kind of
function. It has been supposed that the Na, K-ATPase a-subunit needs
the 13-subunit for its function. By the way, what do we mean by
"function of the a-subunit"? We probably mean its ouabain sensitive
ATPase activity on the plasma membrane. Regarding this, we know
now that (a) the 13-subunit does not affect the affinity for ouabain and
(b) the 13-subunit facilitates the appearance of the a-subunit on the cell
surface. In the latter case, the 13-subunit may be related to stabilization
of the a-13-complex.
FARLEY: Related to the question on the requirement for the
13-subunit, your assay for assembly is based on the immunoprecipita-
tion of the complex by the anti-13-antibody. Can you exclude the
possibility that the antibody binding site on 13 is blocked by the
carboxy-terminal domain of the Ca pump in Chimera I?
LUCKIE: I don't think we can, but we think that it is very unlikely,
considering that Chimera II assembles with the 13-subunit very well.
RAO: Ca stimulated the ATPase activity of Chimera I but did not
appear to be transported. Are you considering adding back segments
of the Ca pump to try to restore Ca transport?
LUCKIE: Yes. We have made a construct consisting of the NH,
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terminal of the Ca pump up to the phosphorylation site, the cytoplas-
mic loop of the Na-K ATPase, and the COOH terminal of Ca pump
containing M5-MI0 domains. The properties of this Chimera are now
under investigation.
KEITH MILLER: Basica:lIy, is the expression in relatively low quanti-
ties. What sort of expression level are you getting now?
LUCKIE: Let's see, in a very large scale transfection, I can get - mg
total protein. Five to ten percent of these proteins are usually the
transfected proteins.
MILLER: It looks like you can begin to talk about structural studies
with NMR.
CHRISTOPHER PENNINGTON: Where are the Na and K binding
sites on the chimeric proteins?
LUCKIE: To answer your question is the major aim of our experi-
ments. Unfortunately, we have not yet identified them. Kadish has
shown that the 19-kD peptide, the last part of a-subunit, is responsible
for Rb binding. So we hope Chimera II will show a similar result in Rb
binding.
FARLEY: I just mention that there are certain cautions to be taken
about the 19-kD peptide results. I do not think it has been shown that
the transmembrane segments actually separate from the structure, so
the Rb binding site may well be on the other transmembrane segments
too.
LUCKIE: That is true.
RAO: Just some comments. The homology between Ca and Na pumps
is only - 30%, so it is amazing that the two proteins can be spliced
together at different junctions and have partial activity.
LUCKIE: Yes, this kind of construct is a very valuable but tricky
experiment. We think it is important to use conserved regions as splice
junctions.
ROBERT BLUMENTHAL: How does chemical cross-linking work to
examine membrane protein subunit interactions.
FARLEY: We can quantitatively cross-link the a-l3-subunit but this
inactivates the enzyme.
MARK McNAMEE: Basically where does the protein end up in
transfected cells? It seems you have done a lot of tinkering.
LUCKIE: Yes, immunofluorescence micrographs of transfected cells
show that Chimera I localized exclusively in the ER, while Chimera II
can be transported to the plasma membrane. This supports the idea
that one l3-subunit is required for sorting to the plasma membrane.
V. LEMAS: In addition, we have been transfecting COS cells using
vaccinia virus, and I realize that we have to be very careful to interpret
the data on fluorescence staining when we overexpress those Chime-
ras. Many of the cells show Chimera II seems to get to the cell surface
but Chimera I is retained in the ER. We have been trying certain steps
by treating cells with cyclohexamide to flush them out of the ER and to
arrive at plasma membrane. Those experiments are still in progress.
FARLEY: Your Chimeras are interesting also in the context of a
paper in J. Bioi. Chern. late last year reporting that a truncated form of
a-subunit is found in smooth muscle. The truncated form is the only
form of Na pump based on either Northern or Western blots. The
truncation occurs after amino acid 554, almost in the middle of the
protein. Have you tried to look for the activities just using Na,K
two-thirds of Chimera I?
LUCKIE: Experimentally, I do not have evidence to support the
functionality of the truncated forms. Doug Fambrough has attempted
to make soluble cytoplasmic domains of the Na-K-ATPase in E. coli to
detect such activity.
LEMAS: We have made some truncated forms accidentally, some of
them are truncated at - 25 amino acids before the junction being used
to construct the Chimera. These truncated forms (e.g., the NHz
terminal two-thirds of ion pumps), give us a very interesting results.
They seem to be retained in ER, and not assembled with the beta
subunit. But we do not know anything about their activities yet.
IRA LEVIN: Let's go back to Keith Miller's question about structural
techniques.
MILLER: If you do compare the differential spectroscopy for getting
information from protein, in this particular case, it will be very nice
information about primary structure. I can comment from the spec-
trum change during conformation change.
DOUGLAS FAMBROUGH: One way to produce mutant ion pump
proteins in large quantities is to use the recombinant vaccinia virus
system and T7 RNA polymerase that Dr. Moss' lab developed. Within
a few hours after transfection, you will get massive amounts of
whatever protein you expressed. It amazed the people who are
interested in structure and function relationships that they put in their
DNA in the morning and by noon saw a large number of molecules on
the surface of the cells. This is the easiest expression system we have
found.
TAKEYASU: I just want to add something else at the end. I have
always been expecting people to argue about our ten-transmembrane-
domain model because it has been very provocative. The 8 spanning
model for Na pump has been generally used, while the 10-
transmembrane model has been well established for the Ca-ATPase.
We have adapted this Ca pump model to the Na pump structure just
because the hydrophobicity profile of both ion pumps are very similar.
Our chimeric molecules have been designed based on this ten
transmembrane model.
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